Diisopropylethylamine → HCID 178446064、化合物

HRID 1655735ノート

反応式

HRID 1655735 の反応式
[NH2:1][C@@H:2]([CH2:23][C:24]1[N:25]=[CH:26][NH:27][CH:28]=1)[C:3]([NH:5][C@@H:6]([CH2:16][CH:17]1[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]1)[C@@H:7]([OH:15])[CH2:8][C@@H:9]([CH:12]([CH3:14])[CH3:13])[CH:10]=[CH2:11])=[O:4].[CH3:29]CN(C(C)C)C(C)C.[C:38]1([CH:44]([C:59]2[CH:64]=[CH:63][CH:62]=[CH:61][CH:60]=2)[C:45]([O:47][C@@H:48]([CH2:52][C:53]2[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=2)[C:49]([OH:51])=O)=[O:46])C=CC=CC=1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)[C:76]2[CH:77]=[CH:78][CH:79]=[CH:80][C:75]=2N=N1>C(#N)C>[CH2:38]([CH:44]([CH2:59][C:64]1[CH:63]=[CH:62][CH:61]=[CH:60][CH:29]=1)[C:45]([O:47][C@H:48]([C:49](=[O:51])[NH:1][C@H:2]([C:3](=[O:4])[NH:5][C@@H:6]([CH2:16][CH:17]1[CH2:18][CH2:19][CH2:20][CH2:21][CH2:22]1)[C@@H:7]([OH:15])[CH2:8][CH:9]([CH:12]([CH3:13])[CH3:14])[CH:10]=[CH2:11])[CH2:23][C:24]1[N:25]=[CH:26][NH:27][CH:28]=1)[CH2:52][C:53]1[CH:54]=[CH:55][CH:56]=[CH:57][CH:58]=1)=[O:46])[C:75]1[CH:80]=[CH:79][CH:78]=[CH:77][CH:76]=1

参加物

6

反応物 4

HCID 81531DiisopropylethylamineHCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 54325350(S)-alpha-(diphenylacetoxy)hydrocinnamic acidHCID 178456019HCID 178456019、化合物

生成物 1

HCID 178446064HCID 178446064、化合物

試薬・触媒・溶媒 1

HCID 6342Acetonitrile溶媒2 回

実験手順

100 mg (0.256 mmol) of (S)-α-amino-N-[(1S,2S,4S)-1-(cyclohexylmethyl)-2-hydroxy-4-isopropyl-5-hexenyl]imidazole-4-propionamide and 0.052 ml of Hunig base in 2 ml of acetonitrile were treated with 92 mg of (S)-α-(diphenylacetoxy)hydrocinnamic acid and 113 mg of BOP in 2 ml of acetonitrile and stirred at room temperature for 12 hours. The reaction solution was then poured onto 1N hydrochloric acid/ice, extracted with ethyl acetate, the organic phase was washed with sodium carbonate solution, dried over sodium sulfate and, finally, the solvent was removed under reduced pressure. The residue was chromatographed on silica gel with a 10:1 mixture of methylene chloride and methanol, to obtain 130 mg of (S)-α-[[(S)-1-[[(1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-4-isopropyl-5-hexenyl]carbamoyl]-2-imidazol-4-ylethyl]carbamoyl]phenethyl dibenzylacetate in the form of an amorphous solid. MS 733 (M+H)+.

後処理

  1. extractionextracted with ethyl acetate
  2. washthe organic phase was washed with sodium carbonate solution
  3. dry with materialdried over sodium sulfate
  4. customfinally, the solvent was removed under reduced pressure
  5. customThe residue was chromatographed on silica gel with a 10:1 mixture of methylene chloride and methanol

出典と根拠

ORDレコード
ord-15269954eb814dc49f2d0c078e5135f2
出典データセット
uspto-grants-1993_10
特許番号
US05250517

反応ノート

読み込み中…